Waters, Advion Finish Evaluating Integration of Synapt MS With NanoMate Infusion Tech | GenomeWeb
NEW YORK (GenomeWeb News) — Waters and Advion Biosciences have completed the evaluation phase of a product-integration effort and have kicked off a co-marketing campaign this week at the LC-MS Montreux Symposium in Switzerland, Waters said.
 
The companies are integrating Advion’s TriVersa NanoMate infusion technology with Waters’ Synapt high definition mass spectrometer into a platform that Waters said will help researchers maximize the information they can pull from large quantities of samples.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.